NSSK has formed a capital and business partnership with Kiito Co., Ltd., aiming to enhance growth and operational efficiencies within the expanding nursing home and hospice care market in Japan.

Target Company Overview

Japan Industry Promotion Organization Group (NSSK), based in Minato, Tokyo, has established a strategic capital and business partnership with Kiito Co., Ltd., headquartered in Nagoya, Aichi Prefecture. Kiito, founded in September 2010, operates 14 nursing homes primarily in Nagoya, providing essential medical services, home care, and nursing services for residents in need. Through its dominant strategies in Nagoya and a strong suite of medical services, Kiito has achieved high occupancy rates and premium pricing. As the number of hospital beds in Japan declines, the demand for nursing homes and hospice care is expanding to accommodate the elderly and terminal patients seeking appropriate care, positioning Kiito as a vital player in this sector.

Industry Overview in Japan

The nursing home and hospice market in Japan is on a growth trajectory, largely driven by the aging population. With a demographic shift leading to an increased number of seniors, the necessity for quality long-term care facilities is becoming more pressing. Furthermore, the government's initiatives to promote home-based care complement this trend, fostering an environment ripe for the expansion of nursing services.

Moreover, the evolving landscape of healthcare also influences the demand for nursing care. With hospitals aiming to reduce occupancy due to limited resources, there is a strategic shift towards rehabili

View Source

Similar Deals

Otsuka Pharmaceutical Co., Ltd. 4D Molecular Therapeutics

2025

Strategic Partnership Bio Therapeutic Drugs Japan
Blackstone CMIC Co., Ltd.

2025

Strategic Partnership Healthcare Facilities & Services (NEC) Japan
Wontech SheepMedical

2025

Strategic Partnership Medical Equipment, Supplies & Distribution (NEC) Japan
KYORIN Pharmaceutical BIODOL Therapeutics

2025

Strategic Partnership Proprietary & Advanced Pharmaceuticals Japan
NTT Docomo Ventures Validic, Inc.

2023

Strategic Partnership Telemedicine Services Japan
Fujimoto Pharmaceutical Corporation Emcitate

2023

Strategic Partnership Proprietary & Advanced Pharmaceuticals Japan

日本産業推進機構グループ (NSSK)

invested in

株式会社キート (Kito Co., Ltd.)

in 2023

in a Strategic Partnership deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert